Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.

JAMA : the Journal of the American Medical Association
Justin E BekelmanInternational Consortium for End-of-Life Research (ICELR)

Abstract

Differences in utilization and costs of end-of-life care among developed countries are of considerable policy interest. To compare site of death, health care utilization, and hospital expenditures in 7 countries: Belgium, Canada, England, Germany, the Netherlands, Norway, and the United States. Retrospective cohort study using administrative and registry data from 2010. Participants were decedents older than 65 years who died with cancer. Secondary analyses included decedents of any age, decedents older than 65 years with lung cancer, and decedents older than 65 years in the United States and Germany from 2012. Deaths in acute care hospitals, 3 inpatient measures (hospitalizations in acute care hospitals, admissions to intensive care units, and emergency department visits), 1 outpatient measure (chemotherapy episodes), and hospital expenditures paid by insurers (commercial or governmental) during the 180-day and 30-day periods before death. Expenditures were derived from country-specific methods for costing inpatient services. The United States (cohort of decedents aged >65 years, N = 211,816) and the Netherlands (N = 7216) had the lowest proportion of decedents die in acute care hospitals (22.2.% and 29.4%, respectively). A hi...Continue Reading

Citations

Mar 10, 2016·Journal of the American Medical Directors Association·Patricia Abele, John E Morley
May 28, 2016·Professional Case Management·Ellen Fink-Samnick
Jun 28, 2016·CA: a Cancer Journal for Clinicians·Alexander Shimabukuro-VornhagenMichael S von Bergwelt-Baildon
Nov 5, 2016·Journal of Critical Care·Kwadwo KyeremantengDavid Neilipovitz
Jun 28, 2016·Annals of the American Thoracic Society·Katherine R CourtrightScott D Halpern
Sep 15, 2016·Journal of Palliative Medicine·Gabriel A BrooksJoseph O Jacobson
Sep 25, 2016·BMC Health Services Research·A Brinkman-StoppelenburgA van der Heide
Oct 13, 2016·BMC Palliative Care·Kaisa RajalaM Myllärniemi
Sep 2, 2016·Journal of Intensive Care Medicine·Kwadwo KyeremantengGianni D'Egidio
Jan 19, 2017·Critical Care Medicine·J Randall Curtis, Mark R Tonelli
Jun 19, 2016·Palliative Medicine·Peter TanuseputroWalter P Wodchis
Jul 28, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly M TrevinoHolly G Prigerson
Sep 8, 2016·Journal of Oncology Practice·Bobby DalyBlase N Polite
Mar 11, 2017·Journal of Palliative Medicine·Donna M WilsonStephen Birch
Nov 29, 2016·Journal of Palliative Medicine·Michelle HowardPeter Tanuseputro
May 2, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emmanuelle KempfLucas Morin
Jun 9, 2017·Journal of Oncology Practice·Alison WiesenthalDeborah Korenstein
Jul 16, 2017·American Journal of Obstetrics and Gynecology·Benjamin MargolisJason D Wright
Mar 14, 2018·The American Journal of Hospice & Palliative Care·Zhe ZhangWen-Wu Cheng
Dec 1, 2017·Journal of Palliative Medicine·Kieran Quinn, Stephen Workman
Nov 2, 2017·Journal of Palliative Medicine·Andrew M Ryan, Phillip E Rodgers
Dec 22, 2017·Journal of Intensive Care Medicine·Andrew S EpsteinLeonard B Saltz
Mar 6, 2018·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·France VrijensJan P Van Meerbeeck
Apr 5, 2017·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Rashidul Alam MahumudAlec Morton
Aug 20, 2017·Emergency Medicine Journal : EMJ·Ziad Obermeyer
Nov 25, 2017·The American Journal of Hospice & Palliative Care·Nina R O'ConnorSalimah H Meghani
Mar 8, 2017·Health Affairs·Erin Murphy ColliganShriram Parashuram
Jul 7, 2017·Health Affairs·Kuldeep N YadavKatherine R Courtright
Jun 9, 2018·Journal of Palliative Care·André R MaddisonAndrew Smaggus

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.